These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Kenney C; Jankovic J J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461 [TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm. Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705 [TBL] [Abstract][Full Text] [Related]
6. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393 [TBL] [Abstract][Full Text] [Related]
7. Facial muscle spasms: an Australian study. Kowal L; Davies R; Kiely PM Aust N Z J Ophthalmol; 1998 May; 26(2):123-8. PubMed ID: 9630292 [TBL] [Abstract][Full Text] [Related]
8. [Hemifacial spasm]. Krystkowiak P Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481 [TBL] [Abstract][Full Text] [Related]
9. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
10. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome. Bastola P; Chaudhary M; Agrawal JP; Shah DN Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735 [TBL] [Abstract][Full Text] [Related]
11. A novel task-specific dystonia type: Hemifacial spasm in a photographer. Kargiotis O; Geka A; Tsivgoulis A; Veltsista D; Xiromerisiou G; Tsivgoulis G Neurol Sci; 2021 Mar; 42(3):1151-1152. PubMed ID: 33156408 [TBL] [Abstract][Full Text] [Related]
12. [Clinical symptoms, diagnosis and treatment of focal dystonias]. Klivényi P; Vécsei L Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645 [TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin in the treatment of facial dystonia: evaluation of its efficacy and patients' satisfaction along the treatment]. Costa PG; Aoki L; Saraiva FP; Matayoshi S Arq Bras Oftalmol; 2005; 68(4):471-4. PubMed ID: 16322831 [TBL] [Abstract][Full Text] [Related]
14. Blepharospasm and Hemifacial Spasm. Yen MT Int Ophthalmol Clin; 2018; 58(1):1. PubMed ID: 29239872 [No Abstract] [Full Text] [Related]
15. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment]. Costa PG; Cardoso IP; Saraiva FP; Raiza AC; Tanaka LK; Matayoshi S Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952 [TBL] [Abstract][Full Text] [Related]